Funding Opportunities

Innovate UK, SBRI Healthcare & NHS

SBRI

The Small Business Research Initiative for Healthcare (SBRI Healthcare) is an NHS England initiative, championed by the Academic Health Science Networks (AHSNs), which supports a programme of competitions inviting companies to come forward with their ideas and new technologies for known NHS challenges. These ideas are assessed and a fully funded development contract is agreed between the company and the NHS.

The SBRI Healthcare programme has two primary-phases that start with an initial identification of unmet need, undertaken by clinicians. Challenges are offered to industry to test the feasibility of their ideas and these projects, if successful, can result in a contract to develop the product

SBRI Healthcare is a fast track, simplified process that enables the NHS to work with industry to tackle known challenges. Targeted at SMEs and early stage businesses it gives vital funding for a critical stage of product development. For details about how to apply and current and future completion thematic areas visit www.sbrihealthcare.co.uk 

SBRI Healthcare Programme – Funding offer launched for Cardiovascular Disease and Integrated Care & Social Care
Companies and organisations are being invited to bid for funding to develop solutions to challenges in:

• Cardiovascular Disease (CVD), including the following sub-categories:
o Detection and Prevention
o Intervention and Invasive Investigations
o Efficiency of CVD pathway

• Integrated Care and Social Care, including the following categories:
o Improve effective data sharing system across the care network
o Reduce social care workforce pressure

SBRI Healthcare is funded by NHS England to develop innovative products and services that address unmet health needs. Phase 1 is intended to show the technical feasibility of the proposed concept. The development contracts placed will be for a maximum of 6 months and up to £100,000 (inc. VAT) per project.
This Competition has been supported by the following AHSNs: Health Innovation Network South London, Innovation Agency AHSN for the North West Coast, South West AHSN and Health Innovation Manchester, but applications are invited from across England. Briefing events with clinicians for interested companies will take place in London on 01 July 2019 and Manchester on 10 July 2019. Details on how to register to the briefing events are available on the SBRI Healthcare website
Deadline: 14 August 2019
Click here for more information

SBRI Healthcare: New competition
SBRI Healthcare has launched a new competition covering Cardiovascular Disease, including the sub-themes of detection and prevention, intervention and invasive interventions, as well as efficacy of the CVD Pathway. The competition will also cover Integrated Care and Social Care, including the following sub-themes: improving effective data sharing across the care network; and reducing social care workforce pressure.
Deadline: 14 August 2019, midday
Click here for more information.

SCR Growth Hub: Scale-Up Initiative
The SCR Scale-Up Initiative, is aimed at accelerating the growth of high-potential businesses through peer focused business learning, group working and industry insight. It will support established businesses to grow where they are ambitious to achieve high levels of growth. The initiative is delivered in collaboration with the University of Sheffield, Sheffield Hallam University and the SCR Growth Hub. It will consist of a programme of activity including learning modules spread over three months to allow busy leaders to participate.
The confirmed learning modules will take place on the following dates, interspersed with 1-2-1 sessions between each business and their dedicated Business Growth Specialist:
• Wednesday 11th September
• Thursday 3rd October
• Wednesday 6th November
• Monday 25th November
Deadline: 29 July 2019
Click here for more

Doncaster Borough Council: Get Doncaster Moving Communications & Marketing
Applicable only if you collaborate with a partner.
The proposal for a Communications & Marketing partner to deliver behaviour change methods around Physical Activity in Doncaster with regards to the ‘Get Doncaster Moving’ initiatives with the vision of “Healthy & Vibrant Communities through Physical Activity and Sport.”
The proposed requirement is to identify what narrative, messages and stories are important, who the messengers are, and the ways to connect people in a way that spreads ideas.
Deadline: 12 August 2019
Click here for more information.

INNOVATE UK

KTPs: Next Funding Round
Projects can focus on any technology or industry area, and last between 1 to 3 years.
Applicants must:
• focus on a specific project
• set out the nature and goals of the project
• give details of who will take part
• establish what the graduate is expected to deliver
Deadline: 24 July 2019
Click here for more information.

Innovate UK: Artificial intelligence-supported early fracture diagnosis: SBRI competition
This is a Small Business Research Initiative (SBRI) competition funded by Opportunity North East and NHS Scotland. Successful applicants will receive 100% funding and have access to advice from NHS Grampian, NHS Greater Glasgow and Clyde (NHSGGC), the University of Aberdeen, the Canon Medical Research Europe and the funders.
The overall programme will be delivered in 2 phases. A decision to proceed with phase 2 will depend on the outcomes from phase 1. Only successful applicants from phase 1 will be able to apply to take part in phase 2.
NHS Scotland and Opportunity North East (ONE) are investing up to £240,000, including VAT, in innovative data analytics technology. The aim is to improve front-line clinical decision making and patient management in unscheduled care facilities.
The solution will improve clinical workflow and safety by optimising clinical decision making and management pathways. It must use artificial intelligence (AI) or machine learning algorithms to interpret data from upper limb (wrist or hand) and lower limb (ankle or foot) radiographs and linked text-based reports. Accurate determination of the presence or absence of a fracture in these areas has the potential to significantly improve patient care.
Phase 1 research and development contracts will be focused on feasibility studies. Phase 2 contracts will be prototype development and testing.
Deadline: 24 July 2019, 12.00pm
Click here for more information.

Innovate UK: SMART programme
Innovate UK’s Smart programme is for the very best ideas from business, no matter what field they are in or the stage of innovation they are at, from testing the feasibility of an idea through to development and prototyping.
The programme is for business innovation projects that offer a major step-change, either to what’s already available or by developing an entirely new technology, service or process.
Innovate UK is looking for new game-changing or disruptive processes or services that have the potential to improve and transform people’s lives, industries and the world.
These ideas should have a considerable positive impact to UK productivity and the economy and a high potential for commercialisation within the UK and wider global markets.
All proposals must be business focused, rather than pure research. Applications can come from any area of technology (including arts, design, media or creative industries), science or engineering and be applied to any part of the economy
Deadline: 24 July 2019
Click here for more information.

Innovate UK: Innovation Loans for SMEs
The programme is being extended to the end of 2020 with an additional £25 million available for business innovation projects in 2 further competitions. Loans will be used to help businesses to support cutting-edge innovations become successful commercial realities.
Previous successful applicants of Innovation Loans include:
• Callaly, a new feminine hygiene care product manufactured entirely in the UK which has had further success following their loan
• Ashwood Electric Motors, creating smaller, lighter and more efficient permanent magnet electric motors
• The Electrospinning Company, making clinical-grade biomaterials
In this current competition, a share of £10 million is available. There is a briefing event at Eagle Labs, Sheffield on 25 July.
Deadline: 11 September 2019
Click here for more information.

Innovate UK/EUREKA Network: Singapore/UK Collaborative R&D
The competition aims to support the development of collaborative research and development projects between the UK and Singaporean companies. Although the competition scope is open to any sector, applications are particularly encouraged in:
1. medical technology
2. smart mobility and logistics
3. advanced manufacturing
Projects must be collaborative, including at least 1 business from Singapore and 1 from the UK, independent from each other, and show:
* a clear game-changing, disruptive and innovative idea leading to new products, processes or services                                                                                                                                                  *a strong and deliverable business plan that demonstrates awareness of market potential and needs
* a clear route to market within 2 to 3 years of project completion.
Deadline: 19 September 2019
Click here for more information.

NHS

NHS England + UK Space Agency: multi-million pound drive to improve patient care
The UK Space Agency has announced it is allocating up to £4 million to find hi-tech solutions to the major health and care challenges facing the NHS in its 70th anniversary year in a joint initiative with NHS England.
These challenges are:
•Managing long term conditions including joining up health and care services
•Earlier diagnosis of cancer
•Transforming GP services and other primary care
•Meeting mental health needs
Previous examples of space tech being adapted for NHS use include a pill camera that can be swallowed by patients, dementia tracking slippers, breast screening vans that beam images back to assessment centres, wearable monitors to help prevent falls among the elderly and apps that help prevent skin cancer.
Deadline: none stated
Click here for more information.

NHS TENDERS

NHS England: Supply of various medical products
Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

Specialised – Bleeding Disorders

Specialised – Normal Human Immunoglobulins 

Open future opportunity – This means that the buyer is not yet ready to invite applications, but early notification has been provided and some dialogue may be possible.

NHS Supply Chain: Patient Monitoring Equipment and Related Accessories/Services
NHS Supply Chain intends to launch a National Framework Agreement for the provision of the following types of Monitoring Systems:

– spot check
– vital signs
– patient (low, Mid and High Acuity)
– pre-hospital transport
– Magnetic Resonance Imaging (MRI) compatible
– central station
– telemetry
– foetal
– cardiac output, Electroencephalograph (EEG) and
– electromyography (EMG)
– transfer (individual patient modular monitor).

Please note that this framework will not cover the purchase of consumables alone. For the avoidance of doubt consumables will only be in scope of the proposed Framework if purchased alongside the types of equipment, as stated in any subsequent specification. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 40 000 000 GBP in the first year of this Framework Agreement. However, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
Deadline: approach to market 24 July 2019
Click here for more information.

NHS Supply Chain: Magnetic Resonance (MR) Guided Radiotherapy Treatment Systems
Magnetic Resonance (MR) guided radiotherapy treatment systems including associated options, upgrades, accessories, hardware, software and building works. Note that all applicants must be able to supply a MR radiotherapy treatment system in order to put forward a tender and in order to be successfully-awarded to any future Framework Agreement. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 16 000 000 GBP in the first year of the Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is 64 000 000 GBP.
Deadline: approach to market 6 September 2019
Click here for more information.

NHS England: Low Calorie Diets Programme – Early Market Engagement
This Notice solely relates to early market engagement around the development of a Low Calorie Diets (LCD) programme, which will aim to pilot optimal implementation models for programmes delivering European standard total diet replacement (TDR) products to people diagnosed with Type 2 diabetes.
NHS England wishes to notify potential providers about its intention to commence early market engagement in advance of a potential commissioning process to support its emerging Low Calorie Diets programme. The programme will seek to provide a total diet replacement product alongside a structured programme of support including food reintroduction and weight loss maintenance to people with Type 2 diabetes.
Deadline: 12 September 2019
Click here for more information.

NHS Supply Chain: Patient Assessment Devices
Blood Pressure Monitoring products, Otoscopes and Ophthalmoscopes, Reusable Stethoscopes, Patient Weighing Scales and Measuring Devices, Proctoscopes (Rectoscopes), Sigmoidoscopes and Anoscopes, Dermatoscopes, Personal Health Monitors, Assessment Lights, General Patient Assessment Products inclusive of Disposable/Single Patient Use Stethoscopes and General Patient Assessment Consumables.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 3 100 000 GBP to 3 400 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Initially a 2 year Framework Agreement with an option to extend for a further period of 2 years. Estimated value, range between 12 400 000 GBP and 13 600 000 GBP.
Deadline: Approach to market date is 20 September 2019
Click here for more information.

NHS Calderdale, Greater Huddersfield & North Kirklees CCG: Posture & Mobility (Wheelchairs) Service
NHS Calderdale, Greater Huddersfield and North Kirklees Clinical Commissioning Groups (CCGS) intend to procure a Wheelchair service to carry out assessments and to supply and maintain wheelchairs.
The service will be required to demonstrate:
• A commitment to providing for the holistic needs of the service user in every aspect of service delivery (i.e. clinical lifestyle, social, educational)
• Design and delivery of services that are personalised, with the service user at the heart of what they do
• An ongoing expectation of quality and service improvement and innovation demonstrated by the provider(s)
• Continued professional development among staff demonstrated by provider(s)
• A commitment to, and evidence from the provider of excellent service user experience, and involvement
• A strong commitment to partnership working with related services and the voluntary sector
• A modern IT system with the ability to accurately record and track activity
• A focus on value for money
The service will be procured as two separate Lots:
Lot 1 – Assessment for wheelchairs
Lot 2 – Supply, maintenance and repair of wheelchairs
Deadline: 1 October 2019
Click here for more information.

NHS Supply Chain: Respiratory and Suction Consumables
This framework is for the supply of respiratory and suction consumables with products covering; facemasks, nasal cannula, nebulisation products, oxygen tubing, venture barrels, sterile water, humidification products, catheters and connectors, air cushion, anaesthetic facemasks, manual resuscitators, re-breathing bags, corrugated tubing, resuscitation dummy/mannequin, anatomical anaesthetic facemasks, compressor nebulisor, spirometer, bacterial viral filter, suction catheters, suction tubing, yankauers, suction canisters, chest drainage devices, manual and powered suction devices.
Deadline: 1 November 2019
Click here for more information.

NHS Supply Chain: Collaborative Procurement Partnership: Wheelchair and associated products supply
Powered and Non-Powered Wheelchairs; Wheelbases; Wheelchair Cushions; Special Seating Spares and Associated Products; Service and Maintenance Packages, to include Adult, Bariatric and Paediatric, Heavy Duty Wheelchairs and Associated Products and Accessories.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £8,000,000 to £11,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. £44,000, 000 – £60,000,000 is the estimated value over the total Framework Agreement.
Deadline: 12 November 2019
Click here for more information.

NHS Supply Chain: Non-Invasive Ventilation, Sleep Therapy and Sleep Monitoring
Non-Invasive Ventilation consisting of CPAP, Bi-level and High Flow Therapy devices with associated consumables, sleep therapy devices consisting of CPAP and APAP with associated consumables, sleep monitoring devices consisting of polysomnography, polygraph, respiratory inductive plethysmography, pulse oximetry, blood oxygen saturation sensors and sleep and respiratory managed services consisting of clinical training, patient therapy data monitoring services, consumable management and patient assistance.
Deadline: 1 December 2019
Click here for more information.

NHS Supply Chain: Urology Bowel and Faecal Management
The Framework Agreement will look to include the following range of products – Baby Urine Collection, Bowel and Faecal Management Kits, Catheters, Kits and Maintenance, Catheter accessories, Straps, Valves etc, Catheter Gels, Enuresis Alarms, Mid-Stream Urine Collection, Nephrostomy Urine Drainage, Personal hygiene cleansers, Creams and Foams, Polypropylene Urinals and Funnels, Sheaths, Spigots, Superpubic Catheters, Urine Drainage, Urine Drainage Bags, Urine Meters, Urodynamics. It is anticipated that initial expenditure will be in the region of £18,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £78,000,000
Deadline: early engagement (closing date 11 December 2019)
Click here for more information.

NHS Supply Chain: External Breasts Prostheses and Associated Products
The Framework Agreement will look to include the following range of products – Silicone Full Prosthesis, Silicone Partial Prosthesis, Soft Form Temporary Prosthesis and Post-Operative Bras and Accessories. It is anticipated that initial expenditure will be in the region of £5,000,000 to £8,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £20,000,000 to £32,000,000.
Deadline: 24 January 2020
Click here for more information.

NHS Supply Chain: Robotic Surgical Equipment
To provide a framework for robotic surgical equipment and associated accessories. NHS Supply Chain is conducting market research into robotic surgical equipment, including related accessories/consumables, that cover a wide range of medical procedures including, but not limited to: general surgery, laparoscopic and rthopaedic. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 10 000 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options and growth) is 50 000 000 GBP.
Deadline: 3 February 2020
Click here for more information.

NHS Supply Chain: Sexual Health and Associated Products
This is a PIN.
The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
Deadline: 13 March 2020
Click here for more information.

NHS Calderdale CCG: Care Closer to Home
NHS Calderdale CCG is acting in its capacity as commissioner for healthcare services on behalf of the registered population of Calderdale.
This notice is to advise that the commissioner has determined to seek to develop an alliance in respect of the currently contracted providers of services identified within the scope of ‘Care Closer to Home’. Over the next two years, this will entail the providers of services developing and entering into an overarching agreement with the commissioner and other providers to deliver services under existing service contracts in a more collaborative and integrated way to the population served by the CCG.
During the term of the developmental stage outlined above Commissioners will work to develop a strategy for the future commissioning of services and where appropriate, procurement.
Deadline: 31 March 2021
Click here for more information.